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Abstract
Background: Experimental autoimmune encephalomyelitis (EAE) is used as an animal model for human multiple sclerosis
(MS), which is an inflammatory demyelinating autoimmune disease of the central nervous system characterized by
activation of Th1 and/or Th17 cells. Human autoimmune diseases can be either exacerbated or suppressed by infectious
agents. Recent studies have shown that regulatory T cells play a crucial role in the escape mechanism of Plasmodium spp.
both in humans and in experimental models. These cells suppress the Th1 response against the parasite and prevent its
elimination. Regulatory T cells have been largely associated with protection or amelioration in several autoimmune diseases,
mainly by their capacity to suppress proinflammatory response.
Methodology/Principal Findings: In this study, we verified that CD4
+CD25
+ regulatory T cells (T regs) generated during
malaria infection (6 days after EAE induction) interfere with the evolution of EAE. We observed a positive correlation
between the reduction of EAE clinical symptoms and an increase of parasitemia levels. Suppression of the disease was also
accompanied by a decrease in the expression of IL-17 and IFN-c and increases in the expression of IL-10 and TGF-b1 relative
to EAE control mice. The adoptive transfer of CD4
+CD25
+ cells from P. chabaudi-infected mice reduced the clinical evolution
of EAE, confirming the role of these T regs.
Conclusions/Significance: These data corroborate previous findings showing that infections interfere with the prevalence
and evolution of autoimmune diseases by inducing regulatory T cells, which regulate EAE in an apparently non-specific
manner.
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Introduction
The determinants underlying the heterogeneity of multiple
sclerosis (MS) remain unclear. However, current evidence indicates
the involvement of a complex genetic trait that probably requires an
environmental factor, such as an infection, to be triggered [1].
Classical studies have demonstrated that experimental autoimmune
encephalomyelitis (EAE), an experimental model of MS, can be
either exacerbated or suppressed by infectious agents [2–6]. EAE is
an inflammatory demyelinating autoimmune disease of the CNS
that is characterized by the activation of Th1 and/or Th17 cells
[7,8]. Amplification of the response of these lymphocytes leads to
tissue injury, which can result in demyelination. Regulatory
mechanisms might be activated to down regulate exacerbated
inflammatoryresponses.Indeed,regulatorycellsthatarepositivefor
the expression of the transcription factor Foxp3 have a crucial
function in activating immune suppression and in the maintenance
ofimmune homeostasis[9–11].A deficiencyineitherthenumberor
function of Foxp3-positive T cells has been described in both the
MSand the EAEmodel[12–15].The Foxp3
+IL-10-producingcells
are associated with the recovery phase of EAE, and in vitro-
generated or purified natural regulatory T cells prevent the
induction of EAE by producing IL-10 [16].
On the other hand, some studies have shown that the activation
of T regs, either in experimental models of malaria or in humans
infected by the malaria parasite, suppresses the Th1 response and
prevents elimination of the parasite. The enhancement of
CD4
+CD25
+ regulatory T cells probably plays a crucial role in
this escape mechanism [17–22]. These natural regulatory cells
seem to be associated with a burst of TGF-b production and
decreases in antigen-specific responses and proinflammatory
cytokine production [23].
In the present study, we used experimental malaria infection
and the murine MS model to investigate how the regulatory
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17849mechanisms induced during Plasmodium infection interfere with the
clinical course and immune responses in the EAE model.
Materials and Methods
Animals
C57BL/6 mice (6–8 weeks old) were purchased from the
University of Campinas (Campinas, SP, Brazil) and maintained in
a specific pathogen-free animal facility. All experiments and
procedures were approved by the UNICAMP Committee for
Ethics in Animal Research (Protocol No. 857-1).
Induction of EAE
Briefly, mice were injected subcutaneously (s.c.) with 100 mg/
animal of pMOG35-55 (MEVGWYRSPFSRVVHLYRNGK) or
pCIR180-198 (NPYCNVLTNLKN DYDKIRK) (Genemed Syn-
thesis, CA, USA) emulsified in complete Freund’s adjuvant
containing 4 mg/ml of Mycobacterium tuberculosis H37RA (Difco,
Detroit, MI, USA). Each immunized animal receives a total of
100 ml of the emulsion in the both upper flanks and 200 ng/mouse
of Pertussis toxin intraperitoneal (i.p.) (List Biochemicals, Camp-
bell, CA, USA) on days 0 and 2 after immunization. Clinical
expression of the disease was graded on a clinical index scale of 0
to 5 as previously described [24].
Malaria infection
Mice were infected i.p. with 10
6 infected red blood cells (iRBCs)
of the non-lethal line of P. chabaudi chabaudi AS or were injected
with saline only (negative control group), 6 days after EAE
induction (6 d.a.i) or 25 days prior the EAE induction (post-
infection with P. chabaudi). The group injected with P. chabaudi 6
d.a.i. presented a peak of parasitemia in the same day of EAE
maximum clinical score.
The blood stage forms of both parasites were stored in liquid
nitrogen after in vivo passages in C57BL/6 mice according to a
protocol described elsewhere [25]. The percentage of parasitemia
was determined daily by counting the number of iRBCs among at
least 1,000 erythrocytes in Giemsa-stained blood smears. The
corporal temperatures and relative body weights of the mice were
evaluated daily, starting on day 1 post-infection, by rectal
introduction of a precision digital thermometer (model TE-300,
Instrucamp, Brazil) and with a precision balance (Metter Toledo),
respectively.
Flow Cytometry
All analyses were performed using a flow cytometer (FACScanto
or FACSCalibur) (BD Bioscience, San Jose, CA, USA). For Foxp3
labeling, permeabilization buffer (PBS 10% rat serum and 1%
Triton) was used. The antibodies were as follows: anti-CD4 FITC,
anti-CD4 PE, anti-CD25 PE (BD Bioscience, San Jose, CA, USA)
and anti-Foxp3 APC (eBioscience, San Diego, CA, USA). The
data were analyzed using FACSDiva (BD Bioscience, San Jose,
CA, USA) or MDI 2.9 software.
Cell sorting
All sorting were performed using a cell sorter flow cytometer
FACSAria (BD Bioscience, San Jose, CA, USA). Cells were kept
on ice before and after sorting analysis. Cell purity was confirmed
immediately after sorting and cell viability was assured before the
transfer. Each animal was injected (i.v.) with 1610
6 viable cells.
Quantitative real-time PCR (qRT-PCR)
mRNA was extracted using Trizol and reverse transcribed to
generate cDNA. Taqman analysis was performed using a Taqman
ABI Prism 7500 Sequence Detector (PE Applied Biosystems,
Darmstadt, Germany). The primers GAPDH, IL-17A, IL-10,
TGF-b1, IL-27 and Foxp3 were obtained from Applied Biosci-
ences (Mm00439619_m1 (IL-17A), Mm99999915_m1 (GAPDH),
Mm00475156_m1 (Foxp3),Mm03024053 (TGFb1),Mm00461164
(IL-27), Mm00439616_m1 (IL-10)). The specific mRNAs were
normalized to the expression of a housekeeping gene (GAPDH).
The data were obtained using independent duplicate measure-
ments. The threshold cycle value of the individual measure-
ments did not exceed 0.5 amplification cycles.
Statistical Analysis
The statistical significance of the results was determined using a
non-parametric analysis of variance (Kruskal-Wallis test), the
Mann-Whitney test (U-test) or a non-parametric correlation
(Spearman’s rank). A p value less than 0.05 was considered
significant.
Results
Modulation of EAE and P. chabaudi infection
The inductions of EAE and P. chabaudi infection were designed
to coincide with the peak of the clinical symptoms of EAE. EAE
was more severe approximately 14 days after immunization with
pMOG35-55, and the peak of parasitemia occurred 7 days after
infection (Fig. 1A). The presence of an autoimmune response
during EAE induction did not change the parasitemia levels
(Fig. 1B) or the corporal temperature of the animals during the
course of malaria infection (Fig. 1C). However, the clinical course
of EAE was significantly diminished until 28 days post-EAE
induction (Fig. 1D). The reduction in clinical signs correlated with
a loss of body weight. As shown in Figure 1E, animals with EAE
and infected with P. chabaudi 6 d.a.i presented a modest loss of
body weight relative to the group with EAE alone. Of note,
parasitemia and clinical symptoms of EAE were significantly
negatively correlated during the clinical course of the disease in the
group of mice infected with P. chabaudi 6 d.a.i (Fig. 1F).
Next, we measured cytokine expression by qRT-PCR to verify
whether the reduction in the clinical signs of EAE observed in
infected with P. chabaudi 6 d.a.i was related to differences in the
cytokine expression profile. As shown in Figure 2, a significant
reduction in IL-17A expression was noted in the regional lymph
nodes in the EAE-malaria group in comparison to the EAE group.
Moreover, corroborating the reduction in the pro-inflammatory
profile, we discovered higher expression of IL-10, TGF-b1 and IL-
27 in both lymph nodes in the EAE-malaria mice relative to the
EAE-alone mice (Fig. 2).
Involvement of regulatory T cells
Corroborating with previous studies investigating experimental
malaria infection models [17], the percentages of CD4
+CD25
+
regulatory T cells increased in the spleen as the parasitemia
evolved, with a peak observed on day 4 after infection (6.4%)
(Fig. 3A). By contrast, naı ¨ve mice presented CD4
+CD25
+
percentages (2.0%) were three fold lower than those detected in
malaria-infected mice. A significant difference in the percentage of
T regs was noted on day 4 post-infection in the spleen of EAE
mice when compared to EAE-malaria-infected animals (Fig. 3B).
Indeed, whereas only 6.0% of the cells harvested from EAE mice
were CD4
+CD25
+Foxp3
+ T cells, in the EAE animals harboring a
malaria infection, up to 14.1% of the CD4+ cells expressed
CD4
+CD25
+Foxp3
+. Analyses of peripheral blood cells revealed a
minor increase in the percentage of T reg cells in the EAE-malaria
Malaria-Induced Regulatory T Cells Modify EAE
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e17849Figure 1. Malaria infection P. chabaudi-infected mice 6 d.a.i ameliorates clinical signs of autoimmunity. (A) Experimental design of EAE
induction and P. chabaudi infection. (B) Parasitemia levels, (C) corporal temperature, (D) EAE clinical score and (E) weight loss in groups of mice
infected with P. chabaudi alone (P. chabaudi - black squares), P. chabaudi infected 6 days after EAE induction (P. chabaudi + EAE - white circles), and in
mice harboring EAE alone (EAE - black circles). The results are expressed as the mean of each group of mice (n=5–8) 6 SD. (F) Correlation between
parasitemia level and EAE clinical score in the pool of mice harboring a malaria infection 6 days after EAE induction.
doi:10.1371/journal.pone.0017849.g001
Figure 2. Induction of EAE in Plasmodium chabaudi-infected mice modulates their cytokine expression profile. Expression levels of IL-
17A, IL-10, IL-27 and TGF-b1 measured by qRT-PCR in P. chabaudi infected 6 days after EAE induction (black bars) and the EAE alone (gray bars) group.
The values represent the mean number of specific cytokine gene copies relative to GAPDH in three-five mice 6 SD.
doi:10.1371/journal.pone.0017849.g002
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values did not reach statistical significance (Fig. 3C).
CD4
+CD25
+ regulatory T cell transfer
To verify the participation of CD4
+CD25
+ cells in the
regulation of autoimmune responses during EAE, we transferred
purified CD4
+CD25
+ T cells from P. chabaudi-infected mice four
days after infection into MOG35-55-immunized mice. No parasites
were detected in the CD4
+CD25
+ cell preparation. Sorting
analyses revealed that CD4
+CD25
2 (Fig. 4C) and CD4
+CD25
+
(Fig. 4D) T cells were highly pure (95%62%) and expressed high
levels of Foxp3, as revealed by testing an aliquot of 10
6 sorted cells
(Fig. 4E). Thus, each set (CD4
+CD25
2 or CD4
+CD25
+) of T cells
were transferred intravenously into a different group of MOG35-
55 immunized mice 10 days after EAE induction. The transfer of
CD4
+CD25
+ cells harvested and sorted from EAE-malaria mice
significantly diminished the evolution of clinical signs of EAE
(p,0.01) as compared to animals that were immunized only, or
even to the group that received CD4
+CD25
2 cells (Fig. 4F). Of
note, the anti-inflammatory effect of the T regs was temporary,
because 10 days after the transfer, no significant difference in EAE
clinical scores were found between the two groups.
Longevity of the regulatory T cell effect
To determine whether the malaria-induced regulatory T cells
were able to sustain their anti-inflammatory effect and thereby
prevent mice from developing clinical signs of EAE, we induced
EAE 25 days after infection with P. chabaudi (Fig. 5A). At this time
point, almost no parasites were detected in the peripheral blood
(Fig. 1B). No significant differences in the evolution of the disease
were observed between the group with previous P. chabaudi
infection and the group that was immunized with MOG peptide
only (EAE) (Fig. 5B). Indeed, this observation is consistent with the
low percentage of CD4
+CD25
+ T cells (2.2%) harvested from the
mice 35 days p.i. (Fig. 5C), which did not differ significantly from
the percentage observed in naı ¨ve animals. These results indicate
that the mechanism that suppresses the autoimmune response in P.
chabaudi infection is transitory and does not generate a specific
memory.
Discussion
In the present study, we used P. chabaudi infection and EAE
induction to demonstrate that the immune response to Plasmodium
spp. modulates the autoimmune response.
One of the main challenges of multiple sclerosis is an
understanding its etiology. It is currently well accepted that the
disease results from a genetic predisposition combined with an
environmental factor such as an infection [26]. However, many
recent studies have demonstrated an immunoregulatory role of
infectious agents or their products during the evolution of EAE or
MS [4–6]. In all likelihood, both observations are compatible
Figure 3. Mice harboring a malaria infection display an increase in the percentage of T regs during EAE evolution. (A) Daily
quantification of CD4
+CD25
+ cells in P. chabaudi-infected mice on days 0–7 post-infection. (B) Quantification of CD4
+CD25
+Foxp3
+ cells 4 days post-
infection and/or 10 days after EAE induction. The percentages are relative to the total number of CD4
+ cells and are representative of three
independent assays.
doi:10.1371/journal.pone.0017849.g003
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specific action of each infectious agent and the specific timing of
the infection.
Here, we conducted a study to understand the effects of malaria
infection on the evolution of MS in a murine experimental model.
When EAE induction coincided with the peak of infection in P.
chabaudi-infected mice, we observed a reduction in the clinical
signs of EAE, including weight loss. Of note, we discovered a
negative correlation between the clinical score for EAE and the
percentage of iRBCs. The protective effect of malaria infection on
EAE evolution was correlated with the high expression levels of
IL-10, IL-27 and TGF-b1 and reduced levels of IL-17. Moreover,
an elevated percentage of T regs on day 4 p.i. with P. chabaudi
seemed to play a pivotal role in EAE amelioration. Interestingly,
the presence of a proinflammatory response evoked during EAE
evolution did not alter the evolution of parasitemia. The specific
proinflammatory response to MOG35-55 might not influence
reactivity to malarial antigens. The suppression of immune
responses by Plasmodium parasites might be explained, at least in
part, by the capacity of human or murine iRBCs to convert latent
TGF-b into its bioactive form [27]. The activation of TGF-b by
the parasite might induce the conversion of naı ¨ve T cells into T
reg cells, or it might directly suppress the autoimmune response
[28–29].
In recent years, a growing body of evidence has demonstrated
the importance of T regs in the immunological response induced
during malaria infection in humans [19–22], and in several
experimental models [17,30]. The enhancement of T regs
apparently contributes to the immune evasion mechanism of
Plasmodium spp. and allows parasite development, although this
phenomenon may not hold true for all murine-derived Plasmodium
species [31]. In vitro co-cultures of PBMCs and P. falciparum-
infected red blood cells induce CD4
+CD25
+Foxp3
+ T cells [32],
and a positive correlation between the absolute number of
Figure 4. Transfer of CD4
+CD25
+ regulatory T cells diminishes the clinical signs of EAE. (A) Lymphocytes are gated from whole spleen
cells from a pool of 3–4 mice infected with P. chabaudi.( B) Selection of CD4
+CD25
+ and CD4
+CD25
2 cells before sorting. (C) Purity of the sorted
CD4
+CD25
2 and (D) CD4
+CD25
+ cells. (E) qRT-PCR assessment of expression levels of Foxp3 in CD4
+CD25
+ and CD4
+CD25
2 cells after sorting. The
values represent the mean number of specific cytokine gene copies relative to GAPDH 6 SD. (F) Evolution of the clinical scores of EAE following the
transfer of CD4
+CD25
+ (white circles) or CD4
+CD25
2 cells (black circles). The results represent the mean of three-five mice 6 SD.
doi:10.1371/journal.pone.0017849.g004
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infection has been recently observed [22].
Our data demonstrate a progressive increase in the percentage
of CD4
+CD25
+ T cells during P. chabaudi infection, with a peak
observed on day 4 after infection. These CD4
+CD25
+ T cells
express high amounts of Foxp3 in both P. chabaudi-infected mice
and in P. chabaudi-infected mice 6 d.a.i when compared with EAE-
alone mice. This finding may explain the observed suppressive
effect of malaria infection on the course of EAE. A large number
of reports have highlighted the role of regulatory T cells both in
the prevention of EAE induction [33–34] and in the resolution of
the disease [16,35], mainly via IL-10 and/or TGF-b induction in
these cells [36].
Because CD4
+CD25
+Foxp3
+ T regs are capable of inhibiting
proinflammatory responses by releasing IL-10 and TGF-b1, in our
model and in other autoimmune models [10], it is conceivable that
these CD4
+CD25
+Foxp3
+ T regs might play a central role in
regulating the autoimmune response during Plasmodium infection.
To test this hypothesis, we transferred highly pure sorted
CD4
+CD25
+ T cells from P. chabaudi-infected mice four days after
infection into MOG35-55 immunized mice, avoiding the introduc-
tion of parasites into the system. The adoptive transfer of
CD4
+CD25
+ T cells, which express higher amounts of Foxp3,
but not of CD4
+CD25
2 cells, significantly diminished the clinical
signs of EAE for approximately 10 days, similar to the signs
observed with P. chabaudi-infected mice 6 d.a.i. These results
unequivocally demonstrated the central role of malaria-induced T
regs in the control of EAE development. However, when EAE was
induced in a group of mice with controlled parasitemia, no
amelioration of the clinical signs of EAE was observed, and the
percentage of CD4
+CD25
+ cells was comparable to that in naı ¨ve
animals. Our findings indicate that the process of T reg cell
enhancement is not long lasting and probably does not induce
immunological memory. Indeed, these T regs are rapidly inducible
and short-lived, as previously described [37]. Nonetheless,
malaria-induced T regs are able to suppress responses to non-
malarial antigens [38].
Despite these indications, we tried to establish some cross-
specificity between the MOG protein and P. chabaudi antigens.
Using the Sanger Plasmodium databank, we were able to
demonstrate significant homology between the MOG protein
(NP_034944) and the CIR protein (PC500044.00.0). Five
different regions presented some similarity when the two
proteins were aligned (Fig. S1A). One of these five regions
exactly matched the MOG35-55 peptide (Fig. S1B). However, no
cross-reactivity was observed when this peptide (CIR180-198)w a s
used either to induce EAE in naı ¨ve animals or to treat MOG35-55
immunized animals (data not shown). However, we cannot
exclude the possibility of polyclonal expansion of lymphocytes
promoted by the malaria infection, which may enhance
MOG35-55 specific T regs and thereby cause the phenomena
described herein, albeit in smaller numbers. Nevertheless, our
data provide strong evidence that once activated by the TCR or
during polyclonal expansion, T regs may exert their suppression
in a completely non-specific manner. Indeed, Thornton and
Shevach have proposed this non-specific suppressor mechanism
using an in vitro model system [39]. Moreover, the regulatory
functions of these T regs are probably due to their expression
and release of inhibitory cytokines such as TGF-b and IL-10 in
a standard suppressive manner.
Figure 5. Induction of EAE after recovery from malaria infection does not reduce clinical signs. (A) Experimental design of post P.
chabaudi infection EAE induction in P. chabaudi-infected mice (n=5–7). (B) EAE induction 25 days post-P. chabaudi infection (white circles) or EAE
induction alone (black circles). The results represent the mean of three-five mice 6 SD. (C) CD4
+CD25
+ quantification 25 days post-P. chabaudi infection.
doi:10.1371/journal.pone.0017849.g005
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PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e17849In the present study we describe for the first time the ability of
Plasmodium infection to interfere with the EAE autoimmune
response. Our findings indicate that the T reg cells generated
during P. chabaudi infection act in an apparently non-specific
manner to control the proinflammatory response, mainly via
increased expression of IL-10 and TGF-b1.
Supporting Information
Figure S1 (A) Amino acid sequence alignment of the MOG
(black) and CIR proteins (http://www.ebi.ac.uk: Accession num-
ber: needle-20100715-1546033194.output) (red). Green symbols
indicate identical amino acids; yellow symbols represent conserva-
tive changes and blue symbols represent semi-conservative changes.
(B) Sequence comparison of the MOG35-55 and CIR180-198
peptides.
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